SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-017454
Filing Date
2019-05-09
Accepted
2019-05-08 19:22:58
Documents
68
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q arvn-10q_20190331.htm 10-Q 1868686
2 EX-31.1 arvn-ex311_7.htm EX-31.1 18194
3 EX-31.2 arvn-ex312_6.htm EX-31.2 18167
4 EX-32.1 arvn-ex321_8.htm EX-32.1 9209
5 EX-32.2 arvn-ex322_9.htm EX-32.2 9211
  Complete submission text file 0001564590-19-017454.txt   5956837

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT arvn-20190331.xml EX-101.INS 1066037
7 XBRL TAXONOMY EXTENSION SCHEMA arvn-20190331.xsd EX-101.SCH 53876
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE arvn-20190331_cal.xml EX-101.CAL 47705
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE arvn-20190331_def.xml EX-101.DEF 182558
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE arvn-20190331_lab.xml EX-101.LAB 402167
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE arvn-20190331_pre.xml EX-101.PRE 313192
Mailing Address 395 WINCHESTER AVE 5 SCIENCE PARK NEW HAVEN CT 06511
Business Address 395 WINCHESTER AVE 5 SCIENCE PARK NEW HAVEN CT 06511 203-535-1456
ARVINAS, INC. (Filer) CIK: 0001655759 (see all company filings)

IRS No.: 472566120 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38672 | Film No.: 19808339
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences